Hydralazine Hydrochloride Tablet
Product Images NDC 71335-9722

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71335-9722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Image 01)

Chemical structure of Hydralazine Hydrochloride, illustrating its molecular framework including a fused aromatic ring system and hydrazine functional group with an attached hydrochloride moiety.*

FDA Label Image

Label (Lbl713359722)

Label for Hydralazine Hydrochloride 100 mg tablets, USP, repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by ScieGen Pharmaceuticals, Inc. The label displays NDC 71335-9722-1, contains 30 tablets, and includes storage instructions at 20° to 25°C (68° to 77°F) with allowable excursions. The label highlights child-resistant packaging and includes barcode and lot/expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.